Neglected Tropical Disease News and Research

RSS

WHO report shows serious lack of new antibiotics to combat drug-resistant infections

A report, Antibacterial agents in clinical development - an analysis of the antibacterial clinical development pipeline, including tuberculosis, launched today by WHO shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance.

20 Sep 2017

Small clinical trial shows promise for treating rare neurodegenerative disease

Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20.

11 Aug 2017

NIH researchers show how investigational drug works against rare, fatal genetic disease

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

17 Jul 2017

Rise in antibiotic-resistant gonorrhea, WHO report reveals

Reports from WHO, based on the data collected from 77 countries, reveals that antibiotic resistance of gonorrhea, a common sexually transmitted infection is making the disease much harder and at times impossible to treat.

7 Jul 2017

Entasis and GARDP partner to develop oral antibiotic for treatment of drug-resistant gonorrhea

Zoliflodacin, a novel first-in-class oral antibiotic and one of the only treatments in development to address the rapidly-growing threat of drug-resistant gonorrhea will enter pivotal trials, thanks to a new partnership between the not-for-profit Global Antibiotic Research and Development Partnership and Entasis Therapeutics.

7 Jul 2017

Researchers study Lassa fever patient's immune response and viral persistence

When an American nurse working in West Africa became ill with Lassa fever and was evacuated to the U.S. for treatment in 2016, it provided a rare opportunity.

22 Jun 2017

First-ever clinical study for effective treatment of mycetoma begins in Sudan

The first-ever double-blind, randomized clinical trial for an effective treatment for the severely neglected disease mycetoma has enrolled its first patient at the Mycetoma Research Centre in Khartoum, Sudan.

19 Jun 2017

Chagas disease confirmed as 'silent killer' in first large-scale US survey

A study of almost 5,000 Latin American-born residents of Los Angeles County found that 1.24% tested positive for Chagas disease, a parasitic infection that can cause life-threatening heart damage if not treated early. Chagas disease is one of the leading causes of heart failure in Latin America.

14 Apr 2017

GHIT Fund invests in phase 3 clinical trial for pediatric formulation of ‘snail fever’ drug

The Global Health Innovative Technology Fund, a unique Japanese public-private partnership formed to battle infectious diseases around the globe, today announced 11 new investments totaling US$23 million that could help deliver a range of new innovative therapies for a host of debilitating conditions.

31 Mar 2017

Genome sequencing approach opens door to therapy options for rare, neglected cancers

An international team of scientists led by the Icahn School of Medicine at Mount Sinai and UConn School of Medicine have reported the results of a genome sequencing study for an extremely rare form of cancer.

23 Mar 2017

Innovative ways to target antibiotic resistance in short term

There has been much recent talk about how to target the rising tide of antibiotic resistance across the world, one of the biggest threats to global health today.

3 Mar 2017

New study proves that 'super-boosting' approach may help treat children co-infected with TB and HIV

The non-profit research and development organization Drugs for Neglected Diseases initiative has released results of a study in South Africa that will make it easier for healthcare workers to treat children living with HIV who are co-infected with tuberculosis.

14 Feb 2017

NCATS funds collaboration initiative aimed at repurposing antimalarial to combat Ebola virus

The National Center for Advancing Translational Sciences recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc. to initiate a partnership with Texas Biomedical Research Institute aimed at repurposing an antimalarial for use against the Ebola virus.

10 Nov 2016

Authors call for international efforts to end preventable deaths from breast, cervical cancer

Every year 800000 women die of cervical and breast cancer, but where a woman lives will largely determine her chance of survival.

3 Nov 2016

Two leading non-profit organizations sign strategic affiliation to hasten drug development

The Scripps Research Institute and the California Institute for Biomedical Research - two leading non-profit research organizations - today announced the signing of a strategic affiliation that combines the two organizations into a new biomedical research entity with the tools and know-how to rapidly translate its scientific discoveries into life-saving medicines for the public benefit.

20 Oct 2016

Neglected Tropical Disease News and Research

WHO report shows serious lack of new antibiotics to combat drug-resistant infections

Small clinical trial shows promise for treating rare neurodegenerative disease

NIH researchers show how investigational drug works against rare, fatal genetic disease

Rise in antibiotic-resistant gonorrhea, WHO report reveals

Entasis and GARDP partner to develop oral antibiotic for treatment of drug-resistant gonorrhea

Researchers study Lassa fever patient's immune response and viral persistence

First-ever clinical study for effective treatment of mycetoma begins in Sudan

Chagas disease confirmed as 'silent killer' in first large-scale US survey

GHIT Fund invests in phase 3 clinical trial for pediatric formulation of ‘snail fever’ drug

Genome sequencing approach opens door to therapy options for rare, neglected cancers

Innovative ways to target antibiotic resistance in short term

New study proves that 'super-boosting' approach may help treat children co-infected with TB and HIV

NCATS funds collaboration initiative aimed at repurposing antimalarial to combat Ebola virus

Authors call for international efforts to end preventable deaths from breast, cervical cancer

Two leading non-profit organizations sign strategic affiliation to hasten drug development

Open-source research mechanism could lead to discovery of new, cheap medicines for malaria

Unique open science project shows way for development of new antimalarial treatments

Fiocruz to start phase II clinical trials of novel vaccine for schistosomiasis

New compound could kill parasites of three neglected diseases

People with lymphatic filariasis more likely to acquire HIV infection, study shows

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News